Determination of the Quality of Life Instrument that is most preferred by patients with thyroid cancer

Phase 3

Completed

• Conditions: Head and neck cancer; Cancer; Malignant neoplasm of other and ill-defined sites: head, face and neck

• Registration Number: ISRCTN29843533
• Lead Sponsor: niversity Hospitals Coventry & Warwickshire NHS Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-09-26
• Study Completion: 2013-07-12
• Last Update Posted: 28 May 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 466

Inclusion Criteria

1. Patients 18 years old or over
2. Patients attending the thyroid or head neck cancer clinic who are:
2.1. Being treated or undergoing follow-up for differentiated (papillary or follicular) thyroid cancer or
2.2. Being investigated or treated for differentiated (papillary or follicular) thyroid cancer recurrence
Note: patients with high grade variants such as insular carcinoma or poorly differentiated carcinoma are eligible
3. Male or female

Exclusion Criteria

1. Patients who do not sufficiently understand the English language and those with learning disabilities ? as these are standardized and validated questionnaires which are in English
2. Patients who have medullary thyroid cancer or anaplastic thyroid cancer or lymphoma of the thyroid
3. Patients having a diagnostic hemithyroidectomy for possible thyroid cancer

Study & Design

• Study Type: Observational
• Study Design: Not specified